E3 Ligase Ligand-Linker Conjugates 56

E3 Ligase Ligand-Linker Conjugates 56 Suppliers list
Company Name: Jilin Province Woda Biotechnology Co., Ltd.  
Tel: 13504435624
Email: 1927928688@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: ShenZhen Trendseen Biological Technology Co.,Ltd.  
Tel: 13417589054
Email: trendseenbio@gmail.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
E3 Ligase Ligand-Linker Conjugates 56 Basic information
Product Name:E3 Ligase Ligand-Linker Conjugates 56
Synonyms:E3 Ligase Ligand-Linker Conjugates 56;VHL Ligand-Linker Conjugates 15;(2S,4R)-N-[(2-{2-[4-(1,3-dioxolan-2-yl)phenoxy]ethoxy}-4-(4-methyl-1,3-thiazol-5-yl)phenyl)methyl]-1-[(2S)-2-[(1-fluorocyclopropyl)formamido]-3,3-dimethylbutanoyl]-4-hydroxypyrrolidine-2-carboxamide
CAS:2375564-62-6
MF:C37H45FN4O8S
MW:724.84
EINECS:
Product Categories:
Mol File:2375564-62-6.mol
E3 Ligase Ligand-Linker Conjugates 56 Structure
E3 Ligase Ligand-Linker Conjugates 56 Chemical Properties
Boiling point 953.0±65.0 °C(Predicted)
density 1.36±0.1 g/cm3(Predicted)
pka13.79±0.20(Predicted)
Safety Information
MSDS Information
E3 Ligase Ligand-Linker Conjugates 56 Usage And Synthesis
UsesVHL Ligand-Linker Conjugates 15 incorporates an VHL ligand for the E3 ubiquitin ligase, and a PROTAC linker. VHL Ligand-Linker Conjugates 15 can be used to design PROTACs[1].
IC 50VHL
References[1] Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680. DOI:10.1038/s41589-019-0294-6
E3 Ligase Ligand-Linker Conjugates 56 Preparation Products And Raw materials
Tag:E3 Ligase Ligand-Linker Conjugates 56(2375564-62-6) Related Product Information
Thalidomide-NH-PEG2-C2-NH2 hydrochloride Pomalidomide-PEG3-N3 Pentanediamide, N1-[4-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]butyl]-N5-[19-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-15-oxo-4,7,10-trioxa-14-azanonadec-1-yl]- CAS:2722697-82-5 -PEG4-amine 2,6-Piperidinedione, 3-[4-[[2-(2-aminoethoxy)ethyl]amino]-1,3-dihydro-1-oxo-2H-isoindol-2-yl]-, hydrochloride (1:2)